GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » COGS-to-Revenue

Shanghai HeartCare Medical Technology (HKSE:06609) COGS-to-Revenue : 0.32 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Shanghai HeartCare Medical Technology COGS-to-Revenue?

Shanghai HeartCare Medical Technology's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$42.3 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$134.3 Mil.

Shanghai HeartCare Medical Technology's COGS to Revenue for the six months ended in Dec. 2023 was 0.32.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Shanghai HeartCare Medical Technology's Gross Margin % for the six months ended in Dec. 2023 was 68.46%.

Shanghai HeartCare Medical Technology COGS-to-Revenue Historical Data

The historical data trend for Shanghai HeartCare Medical Technology's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai HeartCare Medical Technology COGS-to-Revenue Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
- 0.51 0.39 0.32 0.30

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only 0.40 0.34 0.31 0.27 0.32

Shanghai HeartCare Medical Technology COGS-to-Revenue Calculation

Shanghai HeartCare Medical Technology's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=75.017 / 254.133
=0.30

Shanghai HeartCare Medical Technology's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=42.348 / 134.27
=0.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai HeartCare Medical Technology  (HKSE:06609) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Shanghai HeartCare Medical Technology's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 42.348 / 134.27
=68.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Shanghai HeartCare Medical Technology COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai HeartCare Medical Technology's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai HeartCare Medical Technology (HKSE:06609) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai HeartCare Medical Technology Corp Ltd (HKSE:06609) » Definitions » COGS-to-Revenue
Comparable Companies
HKSE:06118 HKSE:02170 HKSE:02297 HKSE:02216 HKSE:02393 HKSE:02235 HKSE:02500 HKSE:01612 HKSE:01696 HKSE:02190 ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Website
http://www.strokemedical.com
Shanghai HeartCare Medical Technology Corp Ltd is an innovative neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. Geographically, the Group's revenue is derived from Mainland China.
Executives
Ding Kui 2201 Interest of corporation controlled by you
Wisary Limited 2101 Beneficial owner
Wang Guohui
Shanghai Zandaqian Enterprise Management Consulting Center
Lyfe Capital Management Limited
Lyfe Capital Fund Iii (dragon), L.p.
Shanghai Weiyun Enterprise Management Consulting Partnership (lp)
Lyfe Columbia River Limited
Temasek Holdings (private) Limited
Elbrus Investments Pte. Ltd.
Fullerton Management Pte Ltd
Temasek Life Sciences Private Limited

Shanghai HeartCare Medical Technology (HKSE:06609) Headlines

No Headlines